New Search

Your search found 7 records, sorted by year and then date of acquisition.

1. Baseline Characteristics by Randomization Status in NIDA-CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT). doc type
  May, Jeanine ; Salazar, Dagmar ; Novo, Patricia ; Shmueli-Blumberg, Dikla ; King, Jacquie ; Matthews, Abigail G. ; Rotrosen, John
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Montreal, Canada, June 17-22, 2017.
 
2. Comparative Effectiveness of Extended-Release Naltrexone versus Buprenorphine-Naloxone for Opioid Relapse Prevention (X:BOT): A Multicenter, Open-Label, Randomized Controlled Trial. doc type
  Novo, Patricia ; Lee, Joshua D. ; Nunes, Edward V. ; Bachrach, Ken ; Bailey, Genie L. ; Bhatt, Snehal ; Farkas, Sarah ; Fishman, Marc J. ; Gauthier, Phoebe ; Hodgkins, Candace C. ; King, Jacquie ; Lindblad, Robert ; Liu, David S. ; Matthews, Abigail G. ; May, Jeanine ; Peavy, K. Michelle ; Ross, Stephen ; Salazar, Dagmar ; Schkolnik, Paul ; Shmueli-Blumberg, Dikla ; Stablein, Don ; Subramaniam, Geetha A. ; Rotrosen, John
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Diego, CA, June 9-14, 2018.
 
3. Participants' Preferences for BUP-NX or XR-NTX and Associations with Induction Success and Relapse Rates in the NIDA-CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT). doc type
  King, Jacquie ; May, Jeanine ; Salazar, Dagmar ; Hoehn, Anne ; Shmueli-Blumberg, Dikla ; Novo, Patricia ; Choi-Kuaea, Yunhee ; Peavy, K. Michelle ; Wiebe, Rosson ; Lee, Joshua ; Rotrosen, John
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Diego, CA, June 9-14, 2018.
 
4. Baseline Characteristics of the Opioid Use Disorder Population Enrolled in NIDA-CTN-0051, "Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT)." doc type
  Novo, Patricia ; Nunes, Edward V. ; Scodes, Jennifer ; Pavlicova, Martina ; Lee, Joshua D. ; May, Jeanine ; Salazar, Dagmar ; Shmueli-Blumberg, Dikla ; Rotrosen, John
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Montreal, Canada, June 17-22, 2017.
 
5. Comparative Effectiveness of Extended-Release Naltrexone Versus Buprenorphine-Naloxone for Opioid Relapse Prevention (X:BOT): A Multicentre, Open-Label, Randomised Controlled Trial. doc type doc type
  Lee, Joshua D. ; Nunes, Edward V. ; Novo, Patricia ; Bachrach, Ken ; Bailey, Genie L. ; Bhatt, Snehal ; Farkas, Sarah ; Fishman, Marc J. ; Gauthier, Phoebe ; Hodgkins, Candace C. ; King, Jacquie ; Lindblad, Robert ; Liu, David S. ; Matthews, Abigail G. ; May, Jeanine ; Peavy, K. Michelle ; Ross, Stephen ; Salazar, Dagmar ; Schkolnik, Paul ; Shmueli-Blumberg, Dikla ; Stablein, Don ; Subramaniam, Geetha A. ; Rotrosen, John
 The Lancet 2018;391(10118):309-318. [doi: 10.1016/S0140-6736(17)32812-X].
 
6. NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study Design and Rationale. doc type
  Lee, Joshua D. ; Nunes, Edward V. ; Novo, Patricia ; Bailey, Genie L. ; Brigham, Gregory S. ; Cohen, Allan J. ; Fishman, Marc J. ; Ling, Walter ; Lindblad, Robert ; Shmueli-Blumberg, Dikla ; Stablein, Don ; May, Jeanine ; Salazar, Dagmar ; Liu, David S. ; Rotrosen, John
 Contemporary Clinical Trials 2016;50:253-264. [doi: 10.1016/j.cct.2016.08.004].
 
7. Multisite, Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Trial to Evaluate the Efficacy of Buspirone as a Relapse-Prevention Treatment for Cocaine Dependence. doc type doc type
  Winhusen, Theresa M. ; Kropp, Frankie B. ; Lindblad, Robert ; Douaihy, Antoine B. ; Haynes, Louise F. ; Hodgkins, Candace ; Chartier, Karen ; Kampman, Kyle M. ; Sharma, Gaurav ; Lewis, Daniel F. ; VanVeldhuisen, Paul C. ; Theobald, Jeff ; May, Jeanine ; Brigham, Gregory S.
 Journal of Clinical Psychiatry 2014;75(7):757-764. [doi: 10.4088/JCP.13m08862].
 


Powered by DB/Text WebPublisher, from Inmagic WebPublisher PRO